CRIS Current Research Information System

FONTANA, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.177
AS - Asia 2.534
EU - Europa 2.382
AF - Africa 255
SA - Sud America 111
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 8.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.138
VN - Vietnam 716
SG - Singapore 708
CN - Cina 655
GB - Regno Unito 641
IT - Italia 355
SE - Svezia 341
DE - Germania 303
HK - Hong Kong 171
IN - India 119
NL - Olanda 119
RU - Federazione Russa 116
FR - Francia 113
IE - Irlanda 98
BR - Brasile 88
TG - Togo 75
FI - Finlandia 64
CI - Costa d'Avorio 52
ZA - Sudafrica 52
NG - Nigeria 49
EE - Estonia 44
BG - Bulgaria 33
BE - Belgio 32
JO - Giordania 32
UA - Ucraina 31
CA - Canada 27
KR - Corea 27
CH - Svizzera 24
SC - Seychelles 22
ID - Indonesia 21
AR - Argentina 13
IR - Iran 13
AT - Austria 12
JP - Giappone 12
PL - Polonia 12
ES - Italia 11
GR - Grecia 11
UZ - Uzbekistan 10
BD - Bangladesh 9
MX - Messico 9
EU - Europa 8
AU - Australia 7
AE - Emirati Arabi Uniti 6
MK - Macedonia 6
IQ - Iraq 5
TR - Turchia 5
LT - Lituania 4
PY - Paraguay 4
CL - Cile 3
PK - Pakistan 3
SA - Arabia Saudita 3
TW - Taiwan 3
EC - Ecuador 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BH - Bahrain 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 8.476
Salva come PNG Salva come JPEG
Città #
Southend 586
Dong Ket 521
Singapore 482
Ashburn 388
Chandler 345
Fairfield 252
Ann Arbor 203
Hong Kong 171
Houston 150
Beijing 144
Wilmington 138
Seattle 132
Woodbridge 124
Cambridge 116
Princeton 98
Dublin 97
Santa Clara 88
Boardman 87
Lomé 75
Bologna 61
New York 53
Abidjan 52
Nanjing 45
Westminster 45
Hefei 42
Padova 42
Los Angeles 41
Medford 41
Munich 36
Abeokuta 34
Ho Chi Minh City 34
Helsinki 33
Sofia 33
Amman 32
Brussels 31
Seoul 26
Bremen 24
Dallas 24
Hanoi 24
Berlin 23
Redondo Beach 23
Saint Petersburg 22
Buffalo 21
Redwood City 21
Guangzhou 20
Redmond 20
Milan 19
Turin 19
Bern 18
Hebei 17
Jinan 17
San Diego 17
Frankfurt am Main 16
Lappeenranta 16
Shanghai 16
Shenyang 16
Toronto 16
Changsha 15
Florence 15
Nanchang 15
Jiaxing 14
Turku 14
Jakarta 13
London 13
Tianjin 12
Zhengzhou 11
Chengdu 10
Mountain View 10
Paris 10
São Paulo 10
Tokyo 10
Falkenstein 9
Norwalk 9
Nuremberg 9
Vienna 9
Chennai 8
Düsseldorf 8
Hangzhou 8
Phoenix 8
Taizhou 8
Atlanta 7
Brooklyn 7
Busseto 7
Falls Church 7
Manchester 7
Orem 7
San Francisco 7
Warsaw 7
Chicago 6
Haikou 6
Monmouth Junction 6
Ningbo 6
Romainville 6
Rome 6
Athens 5
Bitola 5
Biên Hòa 5
Bo 5
Hyderabad 5
Johannesburg 5
Totale 5.657
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 337
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 271
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 260
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 242
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 222
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 218
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 216
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 213
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 210
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 206
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 202
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 201
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 197
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 193
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 186
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 185
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 169
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 169
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 169
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 164
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 162
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 161
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 159
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 158
The Genomic and Transcriptomic Landscape of Systemic Mastocytosis 157
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 154
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 154
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 154
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 152
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 151
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 151
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 146
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 137
Effect of production process and high-pressure processing on viability of Listeria innocua in traditional Italian dry-cured coppa 137
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 135
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 133
SNP array reveals a new deletion of JAK2 in AML patients 133
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 132
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 131
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations 128
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 128
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 127
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 125
Single nucleotide polymorphisms as genomic markers for high-throughput pharmacogenomic studies 124
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 121
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x) 119
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 119
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 108
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 107
Effect of production process and high-pressure processing on viability of Salmonella spp. in traditional Italian dry-cured coppa 105
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 89
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 61
PREVALENCE OF SALMONELLA ENTERICA SUBSP. ENTERICA IN HEDGEHOG (ERINACEUS EUROPAEUS) IN FERRARA PROVINCE (EMILIA ROMAGNA, ITALY) 53
EFFETTO DELL’AZIONE DEI RAGGI INFRAROSSI SULLA CARICA BATTERICA PATOGENA DI LATTE CRUDO VACCINO 50
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia 48
Acute myeloid leukemia mutations: Therapeutic implications 34
Totale 8.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.085 0 0 0 0 0 58 75 89 88 42 71 662
2021/20221.115 106 33 53 117 114 56 31 63 57 71 228 186
2022/20231.380 155 202 73 185 105 104 36 67 251 30 119 53
2023/2024394 15 49 17 47 24 101 30 27 21 30 21 12
2024/20251.376 36 217 139 100 110 38 178 62 14 162 74 246
2025/20261.414 311 189 215 212 340 147 0 0 0 0 0 0
Totale 8.673